Cargando…
Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic
IMPORTANCE: Seroprevalence studies complement data on detected cases and attributed deaths in assessing the cumulative spread of the SARS-CoV-2 virus. OBJECTIVE: To estimate seroprevalence of SARS-CoV-2 antibodies in patients receiving dialysis and adults in the US in January 2021 before the widespr...
Autores principales: | Anand, Shuchi, Montez-Rath, Maria, Han, Jialin, Cadden, LinaCel, Hunsader, Patti, Kerschmann, Russell, Beyer, Paul, Boyd, Scott D., Garcia, Pablo, Dittrich, Mary, Block, Geoffrey A., Parsonnet, Julie, Chertow, Glenn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276082/ https://www.ncbi.nlm.nih.gov/pubmed/34251441 http://dx.doi.org/10.1001/jamanetworkopen.2021.16572 |
Ejemplares similares
-
Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis
por: Anand, Shuchi, et al.
Publicado: (2021) -
SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses
por: Montez-Rath, Maria E., et al.
Publicado: (2022) -
SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
por: Anand, Shuchi, et al.
Publicado: (2021) -
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
por: Anand, Shuchi, et al.
Publicado: (2020) -
Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.
por: Anand, Shuchi, et al.
Publicado: (2021)